3376 - 3400 of 8818 Results
Title
Year
-
RESTRICTEDTitle: Validation of Electrochemiluminescence Assays for Highly Sensitive and Reproducible Quantification of α-Synuclein in Cerebrospinal FluidJournal Name: BioanalysisPublisher: Informa UK LimitedVol: 9Issue #: 8Start Page: 621End Page: 630Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4155/bio-2017-0005Citation Count: 12
-
RESTRICTEDTitle: Detection of Proteolytic Signatures for Parkinson's DiseaseJournal Name: Future NeurologyPublisher: Informa UK LimitedVol: 11Issue #: 1Start Page: 15End Page: 32Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/fnl.16.3Citation Count: 0
-
OPENTitle: Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 14Issue #: 6Start Page: 595End Page: 605Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(15)00008-3Citation Count: 169
-
RESTRICTEDTitle: Animal exposure over the life-course and risk of multiple sclerosis: A case-control study within two cohorts of US womenJournal Name: Multiple Sclerosis and Related DisordersPublisher: Elsevier BVVol: 27Issue #:Start Page: 327End Page: 332Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.msard.2018.11.015Citation Count: 5
-
OPENTitle: Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 118Issue #: 9Start Page: 3087End Page: 3097Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci35781Best OA location URL: http://www.jci.org/articles/view/35781/files/pdfCitation Count: 195
-
OPENTitle: Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brainsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 1Start Page: 27End Page: 36Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23442Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6333467Citation Count: 167
-
RESTRICTEDTitle: Enteric GFAP expression and phosphorylation in Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 130Issue #: 6Start Page: 805End Page: 815Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.12742Citation Count: 172
-
OPENTitle: Feasibility of Virtual Research Visits in Fox Trial FinderJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 3Start Page: 505End Page: 515Publication Date:Open Access(OA) Status: OPENLicense: unspecified-oaDOI - Digital Object Identifier: 10.3233/jpd-150549Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150549?id=journal-of-parkinsons-disease%2Fjpd150549Citation Count: 64
-
OPENTitle: Cystinosin, the small GTPase Rab11, and the Rab7 effector RILP regulate intracellular trafficking of the chaperone-mediated autophagy receptor LAMP2AJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 292Issue #: 25Start Page: 10328End Page: 10346Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m116.764076Best OA location URL: https://doi.org/10.1074/jbc.m116.764076Citation Count: 81
-
OPENTitle: The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stressJournal Name: Redox BiologyPublisher: Elsevier BVVol: 19Issue #:Start Page: 62End Page: 73Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.redox.2018.07.021Best OA location URL: https://doi.org/10.1016/j.redox.2018.07.021Citation Count: 81
-
OPENTitle: Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brainsJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 240Issue #:Start Page: 190End Page: 204Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2012.11.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3720241Citation Count: 139
-
OPENTitle: Cortical disinhibition in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 11Start Page: 3408End Page: 3421Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa274Best OA location URL: https://academic.oup.com/brain/article-pdf/143/11/3408/36134872/awaa274.pdfCitation Count: 68
- Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRI2016RESTRICTEDTitle: Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRIJournal Name: Magnetic Resonance Materials in Physics, Biology and MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 2Start Page: 121End Page: 125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10334-016-0590-zCitation Count: 80
-
OPENTitle: The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synucleinJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 110Issue #:Start Page: 68End Page: 81Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2017.11.006Best OA location URL: https://doaj.org/article/e650fb2ac5fe4bd784e66871416f2ba9Citation Count: 48
-
RESTRICTEDTitle: Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor–Nuclear Receptor Related 1 Protein Dimer ActivationJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 59Issue #: 3Start Page: 1232End Page: 1238Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b01702Best OA location URL: https://doi.org/10.7270/q2x63pt7Citation Count: 16
-
OPENTitle: Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disordersJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01468-8Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-022-01468-8Citation Count: 58
-
OPENTitle: LRRK2 activation in idiopathic Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 451Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5429Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6344941Citation Count: 547
-
RESTRICTEDTitle: MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat modelJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 553Issue #:Start Page: 153End Page: 158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2013.08.001Citation Count: 60
-
OPENTitle: Mitostasis in Neurons: Maintaining Mitochondria in an Extended Cellular ArchitectureJournal Name: NeuronPublisher: Elsevier BVVol: 96Issue #: 3Start Page: 651End Page: 666Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuron.2017.09.055Best OA location URL: http://www.cell.com/article/S0896627317309248/pdfCitation Count: 503
-
RESTRICTEDTitle: Kinematic Adaptive Deep Brain Stimulation for Resting Tremor in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 3Start Page: 426End Page: 428Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26482Citation Count: 129
-
OPENTitle: Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic AxonsJournal Name: NeuronPublisher: Elsevier BVVol: 93Issue #: 4Start Page: 882End Page: 896.e5Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2017.01.019Best OA location URL: http://www.cell.com/article/S0896627317300430/pdfCitation Count: 174
-
OPENTitle: Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2Journal Name: Neurochemical ResearchPublisher: Springer Science and Business Media LLCVol: 44Issue #: 6Start Page: 1446End Page: 1459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11064-018-2650-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6450775Citation Count: 11
-
OPENTitle: Essential Tremor in the Elderly and Risk for DementiaJournal Name: Journal of Neurodegenerative DiseasesPublisher: WileyVol: 2014Issue #:Start Page: 1End Page: 5Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2014/328765Best OA location URL: https://downloads.hindawi.com/archive/2014/328765.pdfCitation Count: 22
-
OPENTitle: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLBJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 115Issue #: 51Start Page: E12053End Page: E12062Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1813365115Best OA location URL: https://www.pnas.org/content/pnas/115/51/E12053.full.pdfCitation Count: 83
-
OPENTitle: NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug‐inducible neuroprotection from oxidative stressJournal Name: The FASEB JournalPublisher: WileyVol: 33Issue #: 10Start Page: 11223End Page: 11234Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1096/fj.201900830rBest OA location URL: https://doi.org/10.1096/fj.201900830rCitation Count: 90